Enhanced Detection System for Healthcare-Associated Transmission of Infection
增强型医疗相关感染传播检测系统
基本信息
- 批准号:10297306
- 负责人:
- 金额:$ 77.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-26 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAdultAlgorithmsAreaCenters for Disease Control and Prevention (U.S.)ChildhoodClinicalClinical DataClinical MicrobiologyCollectionComplexComputing MethodologiesDataDatabasesDetectionDevelopmentDisease OutbreaksEconomic ModelsEconomicsElectronic Health RecordEpidemiologyEvaluationGenesGeneticGenomeGenomicsGoalsHealth Care CostsHealthcareHealthcare SystemsHospital CostsHospitalizationHospitalsIncidenceInfectionInfection preventionInfectious Disease EpidemiologyInfluenzaInterruptionInvestigationLaboratoriesLeadLinkMachine LearningMethodsMinisatellite RepeatsMobile Genetic ElementsModelingMorbidity - disease ratePatientsPoliciesPrevalencePreventionPrevention programResearchResidual stateResourcesRespiratory syncytial virusRouteSamplingSeasonsSingle Nucleotide PolymorphismSpecimenSyntenyTestingTimeValidationViralViral Respiratory Tract InfectionVirusacute careadjudicateadvanced analyticsanalytical methodanalytical toolbacterial genome sequencingbasebudget impactdata miningdetection platformeconomic evaluationevidence basegenome sequencinggenomic epidemiologyhealth care settingshealthcare-associated infectionsimprovedinnovationmicrobial genomicsmortalityneglectnovelnovel strategiespathogenpatient safetypreventprospectiverespiratoryrespiratory infection virusrespiratory virussoundsuccesssurveillance datatransmission processviral transmissionwastingwhole genome
项目摘要
Project Summary
Despite recent progress in reducing the incidence of healthcare-associated infections (HAIs), the Centers for
Disease Control and Prevention estimated that 687,000 HAIs occurred in U.S. acute care hospitals in 2015
and that the HAI prevalence on a given day was one in 30 patients. An estimated 72,000 patients died with
HAIs during their hospitalization. In addition, outbreaks in hospitals remain a serious problem but the vast
majority of hospitals use antiquated and ineffective methods to detect them. We established the Enhanced
Detection System for Healthcare Acquired Transmission (EDS-HAT) (R01AI127472), which combines bacterial
whole genome sequencing (WGS) surveillance (as opposed to reactive WGS) to detect outbreaks with data
mining (DM) of the electronic health record (EHR) and machine learning (ML) to identify the responsible
transmission routes. We have demonstrated that EDS-HAT detects both serious outbreaks that were otherwise
unrecognized and novel transmission routes. Despite this success, additional research is needed to improve
upon EDS-HAT and further increase capacity to detect and interrupt hospital outbreaks. For example, hospital
outbreaks of respiratory viruses such as influenza and SARS-CoV-2 are well documented, but this area of
infection prevention is understudied. The addition of respiratory virus surveillance to EDS-HAT would improve
detection and prevention of these costly HAIs. In addition, readily-available clinical microbiology data can be
incorporated into EDS-HAT algorithms to reduce reliance on WGS surveillance. Finally, WGS surveillance
analysis based entirely on core single nucleotide polymorphisms (SNPs) can falsely cluster patients.
Therefore, research to investigate the contribution(s) of the accessory genome is necessary to improve
discriminatory power of EDS-HAT. In this R01 renewal application, we propose to leverage the success of
EDS-HAT by developing additional innovative methods for identification and interruption of hospital-associated
transmission. In aim 1, we plan to use WGS surveillance and EHR DM/ML to study hospital transmission of
respiratory viruses from retrospective (aim 1a) and prospective collections (aim 1b) of respiratory virus positive
specimens at two large academic hospitals (EDS-HAT RV), one for adults and the other pediatric. In aim 2, we
will develop advanced analytic methods to create a version of EDS-HAT that relies primarily on DM/ML of the
EHR (EDS-HAT Lite) (aim 2a) and improve the discriminatory power of WGS to correctly classify patients who
are part of an outbreak (aim 2b). EDS-HAT RV and EDS-HAT Lite will undergo clinical and budget impact
analyses to determine the number of cases prevented and healthcare costs averted. These aims will be
accomplished by a team with expertise in infectious diseases epidemiology, outbreak investigation, infection
prevention, microbial genomics and genomic epidemiology, machine learning and data mining, and economic
analysis and modeling. Our proposed research will lead to improved patient safety and can serve as a model
for how outbreaks are detected and interrupted in hospitals.
项目摘要
尽管最近在减少医疗保健相关感染(HAI)的发生率方面取得了进展
疾病控制和预防估计2015年在美国急诊医院发生了687,000 HAI
并且在特定日期的HAI患病率是30例患者中的1例。估计有72,000名患者死于
海斯在他们住院期间。此外,医院的爆发仍然是一个严重的问题
大多数医院使用过时和无效的方法来检测它们。我们建立了增强
结合细菌的医疗保健收购传输检测系统(EDS帽)(R01AI127472)
整个基因组测序(WGS)监视(与反应性WGS相反)以检测数据爆发
电子健康记录(EHR)和机器学习(ML)的采矿(DM),以识别负责任
传输路线。我们已经证明,EDS帽检测到这两个严重的暴发
无法识别和新颖的传输路线。尽管取得了成功,但仍需要进一步的研究来改进
在EDS帽子并进一步增加了检测和中断医院暴发的能力。例如,医院
呼吸道病毒(如流感和SARS-COV-2)的爆发已得到充分记录,但是
预防感染被研究了。在EDS帽上添加呼吸病毒监测可以改善
检测和预防这些昂贵的HAI。此外,可以轻松获得的临床微生物学数据可能是
纳入EDS帽算法,以减少对WGS监视的依赖。最后,WGS监视
完全基于核心单核苷酸多态性(SNP)的分析可以错误地聚类患者。
因此,必须进行研究以改善附件基因组的贡献。
EDS帽的歧视力。在此R01续订应用中,我们建议利用
通过开发其他创新方法来识别和中断医院相关
传播。在AIM 1中,我们计划使用WGS监视和EHR DM/ML来研究医院的传播
回顾性呼吸道病毒(AIM 1A)和前瞻性收集(AIM 1B)呼吸病毒阳性
两家大型学术医院(EDS HAT RV)的标本,一个用于成人,另一个用于儿科。在AIM 2中,我们
将开发高级分析方法来创建一个EDS帽的版本,该版本主要依赖于DM/ML
EHR(EDS Hat Lite)(AIM 2A),并提高WG的歧视能力,以正确对患者进行分类
是爆发的一部分(AIM 2B)。 EDS HAT RV和EDS HAT LITE将受到临床和预算影响
分析以确定预防案件的数量和避免医疗费用。这些目标将是
由具有传染病专业知识的团队在流行病学,爆发调查,感染方面完成
预防,微生物基因组学和基因组流行病学,机器学习和数据挖掘以及经济
分析和建模。我们拟议的研究将改善患者的安全,并可以作为模型
在医院中如何检测和中断爆发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lee H Harrison其他文献
The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017
美国念珠菌血症流行病学的变化:注射毒品使用作为日益常见的危险因素——美国选定地点的主动监测,2014-2017 年
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Y. Zhang;S. Shrum;Sabrina R. Williams;Sarah Petnic;Joelle Nadle;Helen L. Johnston;Devra M. Barter;B. Vonbank;Lindsay Bonner;R. Hollick;Kaytlynn Marceaux;Lee H Harrison;William Schaffner;B. Tesini;M. Farley;A. Pierce;Erin C. Phipps;K. Mody;M. Chiller;R. Jackson;S. Vallabhaneni - 通讯作者:
S. Vallabhaneni
Lee H Harrison的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lee H Harrison', 18)}}的其他基金
Tracking plasmid spread and transmission in the hospital: A novel tool for infection prevention and control
追踪医院内的质粒传播和传播:感染预防和控制的新工具
- 批准号:
10721660 - 财政年份:2023
- 资助金额:
$ 77.76万 - 项目类别:
Pitt-Mozambique Training Program(Pitt-MozHRTP) in COVID-19, Cardiovascular Disease, and Diabetes in People with HIV
皮特-莫桑比克 COVID-19、心血管疾病和艾滋病毒感染者糖尿病培训计划 (Pitt-MozHRTP)
- 批准号:
10614598 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别:
Pitt-Mozambique Training Program(Pitt-MozHRTP) in COVID-19, Cardiovascular Disease, and Diabetes in People with HIV
皮特-莫桑比克 COVID-19、心血管疾病和艾滋病毒感染者糖尿病培训计划 (Pitt-MozHRTP)
- 批准号:
10471504 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别:
University of Pittsburgh Training Program in Antimicrobial Resistance
匹兹堡大学抗菌素耐药性培训计划
- 批准号:
10371067 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
South Africa-Pittsburgh Public Health Genomic Epidemiology Research Training Program (SAPPHGenE)
南非-匹兹堡公共卫生基因组流行病学研究培训计划 (SAPPHGenE)
- 批准号:
10329934 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
University of Pittsburgh Training Program in Antimicrobial Resistance
匹兹堡大学抗菌素耐药性培训计划
- 批准号:
10590645 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
South Africa-Pittsburgh Public Health Genomic Epidemiology Research Training Program (SAPPHGenE)
南非-匹兹堡公共卫生基因组流行病学研究培训计划 (SAPPHGenE)
- 批准号:
10551302 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
South Africa-Pittsburgh Public Health Genomic Epidemiology Research Training Program (SAPPHGenE)
南非-匹兹堡公共卫生基因组流行病学研究培训计划 (SAPPHGenE)
- 批准号:
9904390 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
University of Pittsburgh Training Program in Antimicrobial Resistance
匹兹堡大学抗菌素耐药性培训计划
- 批准号:
10117170 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
University of Pittsburgh Training Program in Antimicrobial Resistance
匹兹堡大学抗菌素耐药性培训计划
- 批准号:
9788691 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Leveraging Pathogen-Host Networks to Identify Virus-specific and Estradiol-regulated Mechanisms during Respiratory Infection
利用病原体宿主网络来识别呼吸道感染期间的病毒特异性和雌二醇调节机制
- 批准号:
10741119 - 财政年份:2023
- 资助金额:
$ 77.76万 - 项目类别:
Identification of Risk Factors for predicting outcomes of COVID-19-Related Multisystem Inflammatory Syndrome in Children (MISC) using Real World Clinical Data
使用真实世界临床数据识别预测 COVID-19 相关儿童多系统炎症综合征 (MISC) 结果的风险因素
- 批准号:
10527735 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别:
Identification of Risk Factors for predicting outcomes of COVID-19-Related Multisystem Inflammatory Syndrome in Children (MISC) using Real World Clinical Data
使用真实世界临床数据识别预测 COVID-19 相关儿童多系统炎症综合征 (MISC) 结果的风险因素
- 批准号:
10679093 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别:
Systems biological assessment of T cell responses to vaccination
T 细胞对疫苗接种反应的系统生物学评估
- 批准号:
10584571 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别:
Immunologic and Predictive Features of MIS-C
MIS-C 的免疫学和预测特征
- 批准号:
10667530 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别: